NILOTINIB | NILOTINIB | ATC L01XE08
ANTINEOPLASTIC PROTEIN KINASE INHIBITORS CHRONIC MYELOID LEUKEMIA (CML) IC50 VALUES AS INDICATED: BCR-ABL (20-60 NM) PDGFR (69 NM) C-KIT (210 NM) CSF-1R (125-250 NM) AND DDR1 (3.7 NM) | ORAL | Tmax 3 HOUR PPB 98 PERCENT HT 17 HOUR SOLUBILITY IN AQUEOUS SOLUTIONS DECREASES WITH INCREASING PH | BCR-ABL TYROSINE KINASE PDB 3CS9 (HUMAN ABL KINASE IN COMPLEX WITH NILOTINIB) LIGAND CODE = NIL (link to the list of PDB complexes) Download experimental 3D coordinates of NIL with added hydrogens | TYROSINE-PROTEIN KINASE ABL INHIBITOR CHEMBL1862 TYROSINE-PROTEIN KINASE ABL P00519 TYROSINE-PROTEIN KINASE ABL1 HOMO SAPIENS ENZYME KINASE PROTEIN KINASE TK ABL | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |